Gallen Consensus.31 As shown in Table 1,32 this classification involves the immunohistochemical analysis of ER and PR expression;, increased expression and/or induction of the HER2 oncogene;, and the use of the cell proliferation marker Ki-67 as a marker index to classify tumor subtypes. This evidence concerns the gene PGR and neoplasm.